211 – 220 of 241
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2016
-
Mark
Plasma β-amyloid in Alzheimer's disease and vascular disease
- Contribution to journal › Article
-
Mark
Myo-inositol changes precede amyloid pathology and relate to APOE genotype in Alzheimer disease
- Contribution to journal › Article
-
Mark
Alzheimer's disease cerebrospinal fluid biomarkers predict cognitive decline in lewy body dementia
- Contribution to journal › Article
-
Mark
Plasma tau in Alzheimer disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's disease
- Contribution to journal › Article
-
Mark
Cerebrospinal fluid-induced retardation of amyloid β aggregation correlates with Alzheimer's disease and the APOE ε4 allele
- Contribution to journal › Article
-
Mark
A targeted proteomic multiplex CSF assay identifies increased malate dehydrogenase and other neurodegenerative biomarkers in individuals with Alzheimer's disease pathology
- Contribution to journal › Article
-
Mark
Serum neurofilament light protein predicts clinical outcome in traumatic brain injury
- Contribution to journal › Article
-
Mark
Reference measurement procedure for CSF amyloid beta (Aβ)1–42 and the CSF Aβ1–42/Aβ1–40 ratio – a cross-validation study against amyloid PET
- Contribution to journal › Article
-
Mark
The pre-synaptic vesicle protein synaptotagmin is a novel biomarker for Alzheimer's disease
- Contribution to journal › Article
